Copyright
©The Author(s) 2024.
World J Gastrointest Oncol. Apr 15, 2024; 16(4): 1437-1452
Published online Apr 15, 2024. doi: 10.4251/wjgo.v16.i4.1437
Published online Apr 15, 2024. doi: 10.4251/wjgo.v16.i4.1437
Clinical pathological features | Number of cases | AC022424.2 expression, mean ± SEM | P value |
Sex | 0.740 | ||
Male | 37 | 0.068 ± 0.032 | |
Female | 14 | 0.050 ± 0.020 | |
Age in yr | 0.856 | ||
≥ 60 | 32 | 0.067 ± 0.037 | |
< 60 | 19 | 0.058 ± 0.024 | |
Site | 0.508 | ||
Esophagus | 11 | 0.030 ± 0.013 | |
Gastric body/antrum | 40 | 0.071 ± 0.030 | |
Differentiation grade | 0.617 | ||
High–moderate differentiation | 3 | 0.021 ± 0.016 | |
Low–poor differentiation | 48 | 0.067 ± 0.026 | |
Clinical stage | 0.285 | ||
I–II | 18 | 0.098 ± 0.062 | |
III–IV | 33 | 0.044 ± 0.015 | |
Lymph node metastasis | 0.021 | ||
Yes | 35 | 0.014± 0.003 | |
No | 16 | 0.032± 0.008 | |
T stage | 0.311 | ||
T1, T2 | 12 | 0.014 ± 0.004 | |
T3, T4 | 39 | 0.076 ± 0.030 |
- Citation: Wang BS, Zhang CL, Cui X, Li Q, Yang L, He ZY, Yang Z, Zeng MM, Cao N. Curcumin inhibits the growth and invasion of gastric cancer by regulating long noncoding RNA AC022424.2. World J Gastrointest Oncol 2024; 16(4): 1437-1452
- URL: https://www.wjgnet.com/1948-5204/full/v16/i4/1437.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v16.i4.1437